Other competition news
Recent competition outcomes
MedTech and In Vitro Diagnostic Co-operatives
In August 2017, the NIHR announced funding of £14.25 million to 11 NIHR MedTech and In Vitro Diagnostic Co-operatives to develop new medical technologies and provide evidence on commercially-supplied in vitro diagnostic (IVD) tests. The NIHR MICs launched on 1 January 2018, replacing the NIHR Healthcare Technology Co-operatives and NIHR Diagnostic Evidence Co-operatives.
Patient Safety Translational Research Centres
In February 2017, the NIHR announced a £17 million investment into three NIHR Patient Safety Translational Research Centres (PSTRCs). The funding is split between Imperial College NHS Trust and Imperial College London (over £7 million), Salford Royal NHS Foundation Trust and University of Manchester (over £6 million) and Bradford Teaching Hospitals NHS Foundation Trust and University of Leeds (£3 million), to fund the two existing PSTRCs in London and Manchester and a new PSTRC in Yorkshire. The investment will be spent on patient safety research with the centres aiming to turn patient safety discoveries into practice, with previous research undertaken in Manchester and London already having an impact on NHS frontline services.
Clinical Research Facilities
In November 2016, the NIHR announced a £112 million investment in NIHR Clinical Research Facilities (CRFs). The funding was awarded to 23 NHS organisations, which will host the facilities between 1 April 2017 and 31 March 2022. The purpose of the scheme is to provide NIHR funding to meet the necessary recurrent NHS infrastructure costs and NHS Support Costs of funded, world-class, early translational (experimental medicine) research that needs to be undertaken in dedicated, purpose-built CRFs in England, and ensure that funding is targeted appropriately.
Biomedical Research Centres
In September 2016, funding was announced to 20 NHS and university partnerships across England to host NIHR Biomedical Research Centres (BRCs). Each of the BRCs will host the development of new, ground-breaking treatments, diagnostics, prevention and care for patients in a wide range of diseases like cancer and dementia.